Control of Rhine Biotech (002166.SZ) may change hands and trading will be suspended from December 10

Zhitong Finance App News, Rhine Biotech (002166.SZ) announced that the company received a notice from the controlling shareholder and actual controller, Mr. Qin Benjun, on December 8, 2025. Mr. Qin Benjun is planning a change in control of the company and plans to transfer part of the company's shares to the counterparty by agreement and relinquish voting rights for some of the company's shares held by the counterparty. At present, the parties concerned have signed a “Control Change Intent Agreement” on this matter. Trading of the company's shares has been suspended since the opening of the market on December 10, 2025, and is expected to be suspended for no more than 10 trading days.

In addition, the company plans to purchase at least 80% of the shares of Beijing Jinkangpu Food Technology Co., Ltd. (“Beijing Jinkangpu”) by issuing shares and paying cash, while also raising supporting capital from Guangzhou Defu Nutrition. After the transaction is completed, Beijing Jinkangpu will become a holding subsidiary of the company and will be included in the scope of consolidated financial statements.